When it comes to mobility, Central and Eastern European scientists are among the champions. This has often resulted in an entire generational gap in their country’s scientific community. Now, some of the brainiest Eastern European scientists are doing research in the most dynamic research hubs in Western Europe, the US and Asia. And their home countries are left to pick up the pieces. Read more [...]
The position of doctoral candidates in Europe has rarely been more difficult than it is today; this is especially true for scientists working in Central and Eastern Europe (CEE). he past five years have seen many huge changes that have affected the context in which doctoral training is taking place. The first is the inclusion of doctoral training in the Bologna process as a third education cycle. The second is the announcement that the European Commission is aiming to train at least one million more researchers by 2020. The last, but perhaps, the most difficult aspect, is the financial crisis of the past few years; the worst to strike Europe in past 50 years. Read more [...]
Looking East of an imaginary line going through Berlin and Rome all the way to the Urals creates a broad outline of what Eastern Europe is, in the widest geographical definition. What is striking about this broad region is the number of similarities between different countries, not least in science. And yet it is equally surprising how little these countries exchange good practice. Specifically, scientists and policymakers will talk for hours about problems in their country. But few will have much awareness of how similar problems have been overcome in neighbouring countries. Read more [...]
Central and Eastern Europe is proving very attractive to pharma and biotech companies for clinical trials. Highly motivated patients, well-qualified investigators, speed of trials and quality of data as well as lower costs are frequently listed attractions. All together, the population of Central and Eastern Europe represents greater number of people than that of either the United States or the five largest Western European markets combined. Besides, the region also offers a convenient location—at the heart of Europe—for drug and device industries to carry out clinical trials. This article explore in many details the many reasons that makes life science industry come back over and over again to these territories, which have gained their reputation through a combination of rigour, high education levels and historic legacy. Read more [...]
European science conversations by the community, for the community
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
EuroScientist journal 